The fibromyalgia conundrum

Clinical and Experimental Rheumatology

Volumn 27, Issue 5 SUPPL. 56, 2009, Pages

  Mease, P ^a   Buskila, D ^b   Sarzi Puttini, P ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Chronic widespread pain; Fibromyalgia; Fibromyalgia classification criteria; Sleep disturbance

Indexed keywords

EDITORIAL; FIBROMYALGIA; HUMAN; PATHOPHYSIOLOGY;

FIBROMYALGIA; HUMANS;

EID: 77950356792     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Editorial

References (23)

1. BEARD G: Neurasthenia. Boston Med Surg J 1869;80:217-21.
2. OSLER W: The Principles and Practices of Medicine. New York, D. Appleton & Co, 1896.
3. GOWERS WR: Lumbago: Its lessons and analogues. BMJ 1904; 1: 117-21.
4. MOLDOFSKY H, SCARISBRICK P, ENGLAND R, SMYTHE H: Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975; 37: 341-51.
5. YUNUS MB, MASI AT, CALABRO JJ, MILLER KA: Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981; 11: 151-71.
6. RUSSELLD,LARSONAA: Neurophysiopathogenesis of fibromyalgia syndrome: a unified hypothesis. Rheum Dis Clin North Am 2009; 35:421-35.
7. GRACELY RH. PETZKE F, WOLF JM, CLAUW DJ: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002; 46: 1333-43.
8. NEBEL MB, GRACELY RH: Neuroimaging of fibromyalgia. Rheum Dis Clin North Am 2009; 35: 313-27.
9. ABLIN K, CLAUW DJ: From fibrositis to functional somatic syndromes to a bell-shaped curve of pain and sensory sensitivity: evolution of a clinical construct. Rheum Dis Clin North Am 2009; 35: 233-51.
10. STAUD R: Abnormal pain modulation in patients with spatially distributed chronic pain: fibromyalgia. Rheum Dis Clin North Am 2009; 35: 263-74.
11. MARTINEZ-LAVIN M, VARGAS A: Complex adaptive systems allostasis in fibromyalgia. Rheum Dis Clin North Am 2009; 35: 285-98.
12. KUCHINAD A, SCHWEINHARDT P, SEMINO-WICZ DA, WOOD PB, CHIZH BA, BUSHNELL MC: Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J Neurosci 2007; 27: 4004-7.
13. MEASE P: Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 2005; 75: 6-21.
14. MEASE PJ. CHOY EH: Pharmacotherapy of fibromyalgia. Rheum Dis Clin North Am 2009; 35: 359-72.
15. SARZI-PUTTINI P, BUSKILA D, CARRABBA M, DORIA A, ATZENIF: Treatment strategy in fibromyalgia syndrome: where are we now? Semin Arthritis Rheum 2008; 37: 353-65.
16. CLAUWD.I: Fibromyalgia: Update on mecha-nisms and management. J Clin Rheum 2007; 13: 102-9.
17. ARNOLD LM: New therapies in fibromyalgia. Arthritis Res Ther 2006; 8: 212-32.
18. MEASE PJ, CLAUW DJ, ARNOLD LM et al.: Fibromyalgia syndrome. J Rheumatol 2005; 32: 2270-7.
19. MEASE P, ARNOLD LM, BENNETT R et al.: Fibromyalgia syndrome. J Rheumatol 2007; 34: 1415-25.
20. MEASE P, ARNOLD LM, CHOY EH et al: Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol 2009; 36:2318-29.
21. CHOY EH, ARNOLD LM, CLAUW DJ et al.: Content and criterion validity of the preliminary core dataset for clinical trials in fibromyalgia syndrome. J Rheumatol 2009; 36: 2330-4.
22. WOLFE F, CLAUW D, FITZCHARLES MA et al.: Clinical diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010 (in press).
23. SALAFFI F. SARZI-PUTTINI P, GIROLIMET-TI R, GASPARINI S, ATZENI F, GRASSI W: Development and validation of tbe self-administered Fibromyalgia Assessment Status: a diseasespecific composite measure for evaluating treatment effect. Arthritis Res Ther 2009; 11: R125.